Randomized clinical comparison of short term outcomes following endogenous laser ablation and stripping in patients with saphenous vein insufficiency

Size: px
Start display at page:

Download "Randomized clinical comparison of short term outcomes following endogenous laser ablation and stripping in patients with saphenous vein insufficiency"

Transcription

1 Original Research 12 endogenous laser ablation and stripping in patients with saphenous vein Ozgur Bulut*, Umit Halici, Serdar Menekse Department of Cardiovascular Surgery Education and Research Hospital, Samsun, Turkey *Corresponding Author: Department of Cardiovascular Surgery Education and Research Hospital, Baris Bulvari, Kadıkoy Mahallesi, No:199, Ilkadim, 55100, Samsun/Turkey Tel: , Key words: Catheter ablation; quality of life; saphenous vein; surgery; venous Received: Accepted: e-published: Abstract Objectives: The aim was to compare the effects of endovenous laser ablation () and saphenous vein stripping on the quality of life of the patients and their short-term clinical outcomes in the treatment of isolated, symptomatic, unilateral greater saphenous vein (GSV). Materials and Methods: A total of 65 patients undergoing GSV stripping (n = 35) or (n = 30) for GSV (patients demonstrating backflow lasting more than 5 s during Valsalva maneuvers and those with a saphenous vein diameter more than 5 mm) between May 2013 and September 2013 were prospectively included in the study. Groups were compared for differences in clinical, etiological, anatomical and pathophysiological characteristics classification, venous clinical severity scores, and Short Form-36 (SF-36) quality of life scale. Results: Pre-operative and post-operative SF-36 scale scores in both groups were compared statistically and quality of life scores were found to be better in group with lesser number of complaints (P < 0.01). Despite the initial increase in the 1 st week, the venous clinical severity score significantly declined in both groups after treatment, and it was significantly lower in the group at 1 st month. Discussion: In GSV insufficiencies, is an efficient and safe treatment modality with better quality of life outcomes when compared with the stripping method. It offers better short-term relief of symptoms than stripping. Introduction Saphenous vein is an important health problem with its higher prevalence, apparent labor loss and its unfavorable impact on quality of life of the patient, together with its epidemiological and socioeconomical outcomes [1]. In cases of venous ; pain, feeling of heaviness on legs, superficial thrombophlebitis, pigmentation at ankles, formation of white atrophy and ulcerations are symptoms and signs which constitute indications of surgical treatment [2]. Due to the simultaneous involvement of various anatomical and pathophysiological mechanisms in the development of the clinical manifestations of venous, its clinical signs vary greatly. To this end, American Venous Forum organized an international forum in 1994 in order to formulate a comprehensive definition of the condition and use the same terminology for the diagnosis, evaluation and classification of the venous insufficiencies. The forum approved a clinical (C), etiological (E), anatomical (A) and pathological (P) classification of the condition [3,4]. As a complementary to CEAP classification, venous clinical severity scoring system (VCSS) was introduced in order to facilitate its treatment and monitorization of the characteristics of clinical changes occurring during the course of this disease, which is required for the determination of the severity of the disease and proper treatment approach [5,6]. In this study, in the treatment of isolated, symptomatic, unilateral greater saphenous vein (GSV), the effects of endovenous laser ablation () and saphenous vein stripping on the quality of life of the patients and their short-term clinical outcomes were compared. Materials and Methods Study design This study was approved by the local Institutional Review Board. Written informed consent was obtained from all subjects. A total of 65 patients undergoing stripping or

2 Original Research 13 in our clinic between May 2013 and September 2013 with the diagnosis of GSV were included in the study. CEAP classifications and venous clinical severity scores of the patients were evaluated and analyzed prospectively. The age of patients ranged from 18 to 62. The patients were assessed pre-operatively and on post-operative 1 st week and 1 st month. Consecutive patients with symptomatic varicose veins and GSV incompetence, CEAP C2-4EpAsPr, were randomized using sealed envelopes to either surgery or. Inclusion criteria were of GSV and sapheno-femoral junction with reflux at least up to the knee, symptoms of GSV, C2-5, Ep-En, As 1-5 and Pr-Pn. Exclusion criteria; pregnancy, active malignancy, arterial occlusive disease, acute deep vein thrombosis, high risk of pulmonary thromboemboli and deep venous. Outcome parameters All patients underwent venous Doppler ultrasonographic examinations, their vein maps were obtained, source and level of the venous reflux and distribution of the varicose veins were recorded. Before the procedure the patients were classified with respect to their clinical, etiological, anatomical and pathophysiological characteristics. Their VCSS based on scoring of clinical complaints, symptoms and signs were recorded. Short Form-36 (SF-36) quality of life scale was used for the evaluation and comparison of quality of life scores. Pre-operative decision to include patients in the stripping or groups was made upon severity of GSV and diameter of the GSV as detected during diagnostic Doppler examination of the patients. Patients demonstrating backflow lasting more than 5 s during Valsalva maneuvers and those with a saphenous vein diameter more than 5 mm were included in the study. Patients with deep venous were not included in the study. As an outcome of all assessments, patients with established symptomatic GSV, those without any contraindication to these treatment modalities were included in the analysis after they were subjected to CEAP classification and VCSS evaluation. The patients were symptomatic and chosen among those who met the criteria of C2-6, Ep-En, As 1-5 and Pr-Pn classification. In assigned patients, SF-36 questionnaire surveys were performed pre-operatively and on post-operative and in order to evaluate their quality of life. This scale which evaluates both favorable and unfavorable aspects of the health state and consists of subscales of physical function, power of the physical role, physical function, bodily pain, general health state, energy/vitality, social function, role of emotional power, mental health and summary of the physical components [7]. For each subscale, total scores were estimated individually. Health state was evaluated between 0 and 100 points. 0 and 100 pts indicated poor and improved health states, respectively. In every phase, CEAP and VCSS data were retrieved and clinical outcomes were compared. VCSS was evaluated between 0 and 3 points [6]. Statistical analyses Data were analyzed using the Statistical Package for Social Sciences 15.0 for windows (SPSS Inc., Chicago, IL). Parametric tests were applied to data of the normal distribution, and non-parametric tests were applied to data of questionably normal distribution. Repeated-measures analysis of variance was used to compare variable parameters. The distribution of categorical variables in both groups was compared using Pearson Chi-square test. To calculate correlation coefficients Pearson s r, and Kendall s taub was used. Spearman correlation co-efficient followed by the Tukey post hoc test were used to determine correlations between different variables. All differences associated with a chance probability of.05 or less were considered statistically significant. RESULTS A total of 65 consecutive patients (85 legs) were randomized to surgery or. Thirty-seven (56.9%) female and 28 (43.1%) male patients were included in the study. The number of patients and legs treated and examined at follow-up is shown in the consort Diagram 1. Endovenous treatment was applied on GSVs of 20 female (54.0%) and 10 (35.7%) male patients and the remaining patients underwent stripping. Age of the patients ranged between 18 and 62 years. Mean age of the patients in the and surgery groups was 37.8 ± 14.7 and 42.3 ± 11.6 years, respectively. Gender and age were not statistically significant variables in the process of the study. All of the patients were symptomatic at the onset. Clinically the patients were classified in (n = 26; 40%), (n = 18, 27.9%), C 4 (n = 17; 26.1%), and C 5 (n = 4; 6%) categories. Pre-operative venous clinical severity score indicated severe (n = 22; 33.8%), moderate (n = 22; 33.8%) and mild (n = 21; 32.3%) degrees of GSV. Pre-operative evaluation of the patients in the group, venous VCSS indicated severe [3] venous in 12 (40%) patients, however in the post-procedural 1 st week 18 (60%) patients had clinical venous severity score of 0 point, while 12 (40%) patients had mild degrees of [1]. On the 1st month evaluation, VCSS indicated mild (1) degrees of in 4 (13.4%) patients and 26 (96.6%) patients had a VCSS of 0 (e.g., they were asymptomatic). Still in pre-operative

3 Original Research 14 evaluations among 35 patients who underwent stripping, 12 (34.3 %) patients had severe (3) venous at post-operative 1 st week, VCSS pointed out to moderate (2) (n = 12; 34.3%) and mild (1) (n = 23; 65.7%) degrees of venous. On post-operative 1 st month, VCSS represented mild (1) (n = 20; 57.2%) degrees of. While 15 (42.8%) patients were asymptomatic (0). VCSS data were found to be statistically significant (P < 0.01) (Table 1). During post-operative monitorization recanalized flow and thrombophlebitis were observed in 4 (13.3%) patients in the study group. Reintervention and medical therapy were performed. Surgical wound site infection was detected in 3 (8.5%) patients in the stripping group. Signs of venous disappeared in 8 patients (26.6%) in the group at the end of the 1st post-operative month ( ), in 22 (73.4%) patients telengiectasia and partially varicose veins ( ) were observed. At the end of the 1st month among patients who underwent surgical interventions one (2.8%) patient was asymptomatic, while reticular and varicose veins ( ) were observed in 34 (97.2%) patients (Table 2). Pre-operatively and on post-operative 1 st week and 1 st month, patients were evaluated based on SF-36 quality of life scale scoring system and statistically lower pre-operative mental and physical domain scores were detected, while post-operative SF-36 scores were higher and directly proportional to duration of the post-operative period (P < 0.01). In the study group mean pre-operative SF-36 mental component summary score was ± 5.5 pts, while at the 1st week and the 1 st month estimated mean values were ± 4.0 and ± 3.4 pts, respectively. Mean Table 1: VCSS score before and after intervention (P<0.01) VCSS Pre treatment Absent: 0 18 (60) 26 (96.6) Mild: 1 6 (20) 12 (40) 4 (13.4) Moderate: 2 12 (40) 0 (0) Severe: 3 12 (40) 0 (0) Stripping Absent: 0 15 (42.8) Mild: 1 8 (22.8) 23 (65.7) 20 (57.2) Moderate: 2 15 (42.8) 12 (34.3) Severe: 3 12 (34.3) VCSS: Venous clinical severity scoring system, : Endovenous laser ablation pre-operative SF-36 physical component summary score was ± 5.7 pts and on post-operative 1 st week and 1 st month, it was ± 3.8 and 59.9 ± 2.6 pts, respectively. In the stripping group, mean pre-operative SF 36 mental component summary score was ± 5.5 pts, while it was ± 4.1 and ±3.5 pts on post-operative 1 st week and 1 st month, respectively. Mean pre-operative SF-36 physical component summary score was ± 5.7 pts and on post-operative 1 st week and 1 st month it was ± 3.7 and ± 3.0 pts, respectively (Table 3). All of these findings were statistically significant (P < 0.01). Pre-operative and, post-operative SF 36 scale scores in both groups were compared statistically and quality of life scores were found to be better in group with lesser number of complaints (P < 0.01). Graphical distribution of SF- 36 quality of life scale scores is shown in Figures 1 and 2. Table 2: Frequency of CEAP score before and after intervention CEAP Pre treatment 4 (13.3) 8 (26.6) 20 (6.60) 22 (73.4) 15 (50) 6 (20) 10 (33.3) C 4 5 (16.6) C 5 Median Strıppıng 1 (2.8) 11 (31.4) 22 (62.8) 34 (97.2) 8 (22.8) 13 (37.1) C 4 12 (34.3) C 5 4 (11.4) Median Table 3: Quality of life before and after intervention (P<0.01) Quality of life (SF 36) Mental component summary Physical component summary Group stripping stripping Pre operative 37.86± ± ± ±3.3 : Endovenous laser ablation, SF 36: Short Form ± ± ± ± ± ± ± ±3.0

4 Original Research 15 DISCUSSION During the last 10 years, management of varices and venous has seen very important changes. Number of patients treated with methods alternative to stripping is rapidly increasing [8]. New treatment methods replacing classical surgical treatment are ultrasound guided liquid or foam sclerotherapy, radiofrequency ablation, therapy, trans illuminated powered phlebectomy, subfascial endoscopic perforator vein surgery, ambulatory conservative hemodynamic interventions and cryotherapy [9,10]. Mekako et al. compared short-term quality of life and venous severity scores in their venous patients who were treated with stripping or and observed that patients had lower short-term venous clinical severity scores and higher quality of life scores [11]. We also observed that is superior to stripping with respect to short-term outcomes and quality of life scores in that has shorter operative times with lower risk of bleeding and thrombus formation without operative scar tissue, in addition to higher SF36 scale and lower venous clinical severity scores. Kavaus et al. performed on 46 patients with venous in their medical center using laser at a wavelength of 940 nm and published their clinical outcomes [12]. Figure 1. Intergroup comparisons of Short Form-36 quality of life scale mental component data in the post-operative 1 st month. Mental component data in patients in the endovenous laser ablation group were more favorable Figure 2. Intergroup comparisons of Short Form-36 quality of life scale physical component data in the post-operative 1 st month. Physical component data in patients in the endovenous laser ablation group were more favorable Diagram 1. Consort diagram for process from eligibility to analysis

5 Original Research 16 Outcomes of this clinic indicated that the treatment of varices using endovascular laser is a safe and effective treatment modality. In our clinic, we performed at a wavelength of 1470 nm using laser catheter with fiber optic radial tip. Dependent on the diameter of the vein, we used w diode laser. In two patients recanalized blood flow was noted. In 13 patients, we didn t encounter any additional pathology and procedural complication. Since saphenous veins were ablated from 1 cm to 2 cm distal to saphenofemoral junction down to the knee level and adequate amounts of tumescent anesthetic agent were used, nerve and tissue damage were not seen. Pannier et al. indicated that 1470 nm wavelength is more effective than all other wavelengths [12]. In a non-randomized study, Leopardi et al. compared and classical surgery and observed inguinal hematoma in 3.1% the cases who had undergone classical surgery [13]. Thermal burns related to were observed in 2.5% of the cases and in both groups most frequently ecchymosis, paresthesis and induration were seen. Post-operative analgesic use was indicated to be more frequent in the group relative to the classical surgery. During 4 weeks of the follow-up period, saphenous vein was seen in 0.8% of the cases. It has been demonstrated that in the group, quality of life data are more favorable and SF-36 scale scores were higher during the 1 st and 6 th weeks of the follow-up period. In our study, in both groups, though not statistically significant, minor complications (ecchymosis, induration and paresthesias) were observed. In the group of patients, VCSSs estimated at the 1 st and 4 th weeks were statistically significantly lower in the group. In both groups SF-36 quality of life scale scores increased, while in the group they were higher relative to the classical surgery group with better patient satisfaction. CONCLUSION In saphenous vein insufficiencies, which is one of the alternative methods to stripping, is an efficient and safe treatment modality with its shorter procedural time, lack of development of surgical scar, lower bleeding risk and better quality of life outcomes when compared with the stripping method. REFERENCES 1) Nicolaides AN, Allegra C, Bergan J, et al. Management of chronic venous disorders of the lower limbs: Guidelines according to scientific evidence. Int Angiol 2008;27: ) Howard A, Howard DP, Davies AH. Surgical treatment of the in competent saphenous vein. In: Gloviczki P, Dalsing MC, Eklöf B, Moneta GL, Wakefield TW, editors. Handbook of Venous Disorder. 3 rd ed., Vol. 35. London: American Venous Forum, Edward Arnold; p ) Porter JM, Moneta GL. Reporting standards in venous disease: An update. International Consensus Committee on Chronic Venous Disease. J Vasc Surg 1995;21: ) Padberg FT Jr. CEAP classification for chronic venous disease. Dis Mon 2005;51: ) Lozano Sánchez FS, Sánchez Nevarez I, González- Porras JR, et al. Quality of life in patients with chronic venous disease: Influence of the socio-demographical and clinical factors. Int Angiol 2013;32: ) Yang L, Wang XP, Su WJ, Zhang Y, Wang Y. Randomized clinical trial of endovenous microwave ablation combined with high ligation versus conventional surgery for varicose veins. Eur J Vasc Endovasc Surg 2013;46: ) Koçyiğit H, Aydemir Ö, Fişek G, Ölmez N, Memiş A. Knee ınjury and osteoarthritis outcome score: Reliability and validation of the Turkish version. Turkiye Klinik J Med Sci 2007;27: ) Stirling M, Shortell CK. Endovascular treatment of varicose veins. Semin Vasc Surg 2006;19: ) Subramonia S, Lees TA. The treatment of varicose veins. Ann R Coll Surg Engl 2007;89: ) Uncu H. Patient Selection for Endovenous Treatments of the Varicose Veins of Lower Extremity. Turkiye Klinik J Cardiovasc Surg Spec Top 2009;2: ) Mekako AI, Hatfield J, Bryce J, Lee D, McCollum PT, Chetter I. A nonrandomised controlled trial of endovenous laser therapy and surgery in the treatment of varicose veins. Ann Vasc Surg 2006;20: ) Firouznia K, Ghanaati H, Hedayati M, et al. Endovenous laser treatment (EVLT) for the saphenous reflux and varicose veins: a follow-up study. J Med Imaging Radiat Oncol 2013;57: ) Pannier F, Rabe E, Maurins U. First results with a new 1470-nm diode laser for endovenous ablation of incompetent saphenous veins. Phlebology 2009;24:26-30.

Varicose veins that develop due to chronic venous insufficiency

Varicose veins that develop due to chronic venous insufficiency Diagn Interv Radiol 2012; 18:594 598 Turkish Society of Radiology 2012 INTERVENTIONAL RADIOLOGY ORIGINAL ARTICLE Early clinical improvement in chronic venous insufficiency symptoms after laser ablation

More information

Conflict of Interest. None

Conflict of Interest. None Conflict of Interest None American Venous Forum Guidelines on Superficial Venous Disease TOP 10 GUIDELINES 10. We recommend using the CEAP classification to describe chronic venous disorders. (GRADE 1B)

More information

N.S. Theivacumar, R.J. Darwood, M.J. Gough*

N.S. Theivacumar, R.J. Darwood, M.J. Gough* Eur J Vasc Endovasc Surg (2009) 37, 477e481 Endovenous Laser Ablation (EVLA) of the Anterior Accessory Great Saphenous Vein (): Abolition of Sapheno-Femoral Reflux with Preservation of the Great Saphenous

More information

Additional Information S-55

Additional Information S-55 Additional Information S-55 Network providers are encouraged, but not required to participate in the on-line American Venous Forum Registry (AVR) - The First National Registry for the Treatment of Varicose

More information

Surgery or combined endolaser ablation and sclerotherapy for varicose veins, a new trend in a developing country (Iraq); a cohort study

Surgery or combined endolaser ablation and sclerotherapy for varicose veins, a new trend in a developing country (Iraq); a cohort study Surgery or combined endolaser ablation and sclerotherapy for varicose veins, a new trend in a developing country (Iraq); a cohort study Bashar Hanna Azar (1) Ashur Yohanna Izac Oraha (2) Emad Abdulrahman

More information

Prospective evaluation of endo venous laser therapy for varicose vein; early efficacy and complications. The first report from Iran

Prospective evaluation of endo venous laser therapy for varicose vein; early efficacy and complications. The first report from Iran Iran. J. Radiat. Res., 2006; 4 (2): 87-91 Prospective evaluation of endo venous laser therapy for varicose vein; early efficacy and complications. The first report from Iran J. Salimi 1*, F.Yourdkhani

More information

Perforators: When to Treat and How Best to Do It? Eric Hager, MD September 10, 2015

Perforators: When to Treat and How Best to Do It? Eric Hager, MD September 10, 2015 Perforators: When to Treat and How Best to Do It? Eric Hager, MD September 10, 2015 Anatomy of Perforating veins Cadaveric studies 1 have shown >60 vein perforating veins from superficial to deep Normal

More information

Vein Disease Treatment

Vein Disease Treatment MP9241 Covered Service: Yes when meets criteria below Prior Authorization Required: Yes as indicated in 2.0, 3.0, 4.0 and 5.0 Additional Information: None Prevea360 Health Plan Medical Policy: Vein disease

More information

Criteria For Medicare Members. Kaiser Foundation Health Plan of Washington

Criteria For Medicare Members. Kaiser Foundation Health Plan of Washington Clinical Review Criteria Treatment of Varicose Veins Radiofrequency Catheter Closure Sclerotherapy Surgical Stripping Trivex System for Outpatient Varicose Vein Surgery VenaSeal Closure System VNUS Closure

More information

Medicare C/D Medical Coverage Policy

Medicare C/D Medical Coverage Policy Varicose Vein Treatment Medicare C/D Medical Coverage Policy Origination Date: June 1, 1993 Review Date: February 15, 2017 Next Review: February, 2019 DESCRIPTION OF PROCEDURE OR SERVICE Varicose veins

More information

Are there differences in guidelines for management of CVD between Europe and the US? Bo Eklöf, MD, PhD Lund University Sweden

Are there differences in guidelines for management of CVD between Europe and the US? Bo Eklöf, MD, PhD Lund University Sweden Are there differences in guidelines for management of CVD between Europe and the US? Bo Eklöf, MD, PhD Lund University Sweden Disclosures No disclosures Five sources for comparison SVS/AVF US guidelines

More information

chronic venous disorders, varicose vein, CEAP classification, lipodermatosclerosis, Klippel- Trenaunay syndrome DVT CVD

chronic venous disorders, varicose vein, CEAP classification, lipodermatosclerosis, Klippel- Trenaunay syndrome DVT CVD Online publication August 27, 2009 chronic venous disorders: CVD CEAP 4 CEAP CVD J Jpn Coll Angiol, 2009, 49: 201 205 chronic venous disorders, varicose vein, CEAP classification, lipodermatosclerosis,

More information

Determine the patients relative risk of thrombosis. Be confident that you have had a meaningful discussion with the patient.

Determine the patients relative risk of thrombosis. Be confident that you have had a meaningful discussion with the patient. Patient Assessment :Venous History, Examination and Introduction to Doppler and PPG Dr Louis Loizou The 11 th Annual Scientific Meeting and Workshops of the Australasian College of Phlebology Tuesday 18

More information

Thermal Techniques: Outcomes and Complications

Thermal Techniques: Outcomes and Complications Thermal Techniques: Outcomes and Complications Meet The Experts: Thermal and Non-Thermal Ablation Techniques Joseph D. Raffetto MD VA Boston HCS, West Roxbury, MA, Harvard Medical School, Boston, MA; Brigham

More information

Segmental GSV reflux

Segmental GSV reflux Segmental GSV reflux History of presentation A 43 year old female presented with right lower extremity varicose veins and swelling. She had symptoms of aching, heaviness and tiredness in the right leg.

More information

Patient assessment and strategy making for endovenous treatment

Patient assessment and strategy making for endovenous treatment Patient assessment and strategy making for endovenous treatment Raghu Kolluri, MD Director Vascular Medicine OhioHealth Riverside Methodist Hospital Columbus, OH Disclosures Current Medtronic Consultant/

More information

MedStar Health, Inc. POLICY AND PROCEDURE MANUAL Policy Number: MP.066.MH Last Review Date: 11/08/2018 Effective Date: 01/01/2019

MedStar Health, Inc. POLICY AND PROCEDURE MANUAL Policy Number: MP.066.MH Last Review Date: 11/08/2018 Effective Date: 01/01/2019 MedStar Health, Inc. POLICY AND PROCEDURE MANUAL This policy applies to the following lines of business: MedStar Employee (Select) MedStar CareFirst PPO MedStar Health considers the treatment of Varicose

More information

Srovnání 2 typů radiálních laserových vláken (1-ringových a 2-ringových) v nitrožilní léčbě křečových žil pomocí laseru o vlnové délce 1470 nm

Srovnání 2 typů radiálních laserových vláken (1-ringových a 2-ringových) v nitrožilní léčbě křečových žil pomocí laseru o vlnové délce 1470 nm Srovnání 2 typů radiálních laserových vláken (1-ringových a 2-ringových) v nitrožilní léčbě křečových žil pomocí laseru o vlnové délce 1470 nm Robert Vlachovský, Robert Staffa, Ernest Biroš II. chirurgická

More information

Varicose Veins are a Symptom of Vein Disease. Now you can treat the source of your varicose veins with non-surgical endovenous laser treatment.

Varicose Veins are a Symptom of Vein Disease. Now you can treat the source of your varicose veins with non-surgical endovenous laser treatment. Varicose Veins are a Symptom of Vein Disease. Now you can treat the source of your varicose veins with non-surgical endovenous laser treatment. Approximately 1 in 5 adult Americans suffer from superficial

More information

Chronic Venous Insufficiency Compression and Beyond

Chronic Venous Insufficiency Compression and Beyond Disclosure of Conflict of Interest Chronic Venous Insufficiency Compression and Beyond Shawn Amyot, MD, CCFP Fellow of the Canadian Society of Phlebology Ottawa Vein Centre I do not have relevant financial

More information

MOCA and GLUE: results and analyses of the RCTs

MOCA and GLUE: results and analyses of the RCTs MOCA and GLUE: results and analyses of the RCTs Faculty disclosure Research Grant Medtronic Educational Grant mediusa Speakers Bureau Medtronic Pierre Fabre mediusa Medical Director Morrison Vein/Training

More information

Clinical case. Symptomatic anterior accessory great saphenous vein (AAGSV) reflux

Clinical case. Symptomatic anterior accessory great saphenous vein (AAGSV) reflux Clinical case Symptomatic anterior accessory great saphenous vein (AAGSV) reflux A 70 year-old female presents with symptomatic varicose veins on left leg for more than 10 years. She complains of heaviness,

More information

RECOGNITION AND ENDOVASCULAR TREATMENT OF CHRONIC VENOUS INSUFFICIENCY

RECOGNITION AND ENDOVASCULAR TREATMENT OF CHRONIC VENOUS INSUFFICIENCY RECOGNITION AND ENDOVASCULAR TREATMENT OF CHRONIC VENOUS INSUFFICIENCY Paul Kramer, MD, FACC, FSCAI Liberty Cardiovascular Specialists Liberty Regional Heart and Vascular Center DISCLOSURES NONE Venous

More information

Table XI. Reference Abstracts corresponding to references can be found using the listing RCTs by alphabetical order or RCTs by topic.

Table XI. Reference Abstracts corresponding to references can be found using the listing RCTs by alphabetical order or RCTs by topic. Table XI. Operative procedure EVLA with different wavelengths HL+ EVLA EVLA without HL EVLA GSV ablation AK GSV ablation AK+BK Reference Abstracts corresponding to references can be found using the listing

More information

TREATMENT OPTIONS FOR CHRONIC VENOUS INSUFFICIENCY

TREATMENT OPTIONS FOR CHRONIC VENOUS INSUFFICIENCY TREATMENT OPTIONS FOR CHRONIC VENOUS INSUFFICIENCY TL LUK Consultant Vascular Surgeon Sarawak General Hospital HKL Vascular Conference 19/06/2013 PREVALENCE OF LOWER LIMB VENOUS DISEASE Affects half of

More information

Medical Affairs Policy

Medical Affairs Policy Service: Varicose Vein Treatments PUM 250-0032 Medical Affairs Policy Medical Policy Committee Approval 12/01/17 Effective Date 04/01/18 Prior Authorization Needed Yes Disclaimer: This policy is for informational

More information

Non-Saphenous Vein Treatments. Jessica Ochs PA-C Albert Vein Institute Colorado Springs and Lone Tree, CO

Non-Saphenous Vein Treatments. Jessica Ochs PA-C Albert Vein Institute Colorado Springs and Lone Tree, CO Non-Saphenous Vein Treatments Jessica Ochs PA-C Albert Vein Institute Colorado Springs and Lone Tree, CO I have no financial disclosures Types of Veins Treated Perforator Veins Tributary Veins Varicose

More information

PROVIDER POLICIES & PROCEDURES

PROVIDER POLICIES & PROCEDURES PROVIDER POLICIES & PROCEDURES TREATMENT OF VARICOSE VEINS OF THE LOWER EXTREMITIES STAB PHLEBECTOMY AND SCLEROTHERAPY TREATMENT The primary purpose of this document is to assist providers enrolled in

More information

Chronic Venous Insufficiency

Chronic Venous Insufficiency Chronic Venous Insufficiency None Disclosures Lesley Enfinger, MSN,NP-C Chronic Venous Insufficiency Over 24 Million Americans affected by Chronic Venous Insufficiency (CVI) 10 x More Americans suffer

More information

Priorities Forum Statement

Priorities Forum Statement Priorities Forum Statement Number 9 Subject Varicose Vein Surgery Date of decision September 2014 Date refreshed March 2017 Date of review September 2018 Relevant OPCS codes: L841-46, L848-49, L851-53,

More information

OHTAC Recommendation. Endovascular Laser Treatment for Varicose Veins. Presented to the Ontario Health Technology Advisory Committee in November 2009

OHTAC Recommendation. Endovascular Laser Treatment for Varicose Veins. Presented to the Ontario Health Technology Advisory Committee in November 2009 OHTAC Recommendation Endovascular Laser Treatment for Varicose Veins Presented to the Ontario Health Technology Advisory Committee in November 2009 April 2010 Issue Background The Ontario Health Technology

More information

Table VIII. OS versus EVLA. New article

Table VIII. OS versus EVLA. New article Table VIII. OS EVLA. New article Operative procedure OS EVLA for for GSV or SSV incompetence Reference Abstracts corresponding to references can be found using the listing RCTs by alphabetical order or

More information

Endovenous laser obliteration for the treatment of primary varicose veins Vuylsteke M, Van den Bussche D, Audenaert E A, Lissens P

Endovenous laser obliteration for the treatment of primary varicose veins Vuylsteke M, Van den Bussche D, Audenaert E A, Lissens P Endovenous laser obliteration for the treatment of primary varicose veins Vuylsteke M, Van den Bussche D, Audenaert E A, Lissens P Record Status This is a critical abstract of an economic evaluation that

More information

Clinical/Duplex Evaluation of Varicose Veins: Who to Treat?

Clinical/Duplex Evaluation of Varicose Veins: Who to Treat? Clinical/Duplex Evaluation of Varicose Veins: Who to Treat? Sanjoy Kundu MD, FASA, FCIRSE, FSIR The Vein Institute of Toronto Scarborough Vascular Group Scarborough Vascular Ultrasound Scarborough Vascular

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE INTERVENTIONAL PROCEDURES PROGRAMME Interventional procedure overview of endovenous mechanochemical ablation for varicose veins Varicose veins in the legs

More information

The Vascular Disease Almost No One Teaches But Should!!! Chronic Venous Insufficiency

The Vascular Disease Almost No One Teaches But Should!!! Chronic Venous Insufficiency The Vascular Disease Almost No One Teaches But Should!!! Chronic Venous Insufficiency Thomas E. Eidson, DO Certified Venous Disease Specialist Board Certified Family Medicine Disclosure of Conflict of

More information

Thrombosis of the Saphenous Vein Stump after Varicose Vein Surgery

Thrombosis of the Saphenous Vein Stump after Varicose Vein Surgery 2016 Annals of Vascular Diseases doi:10.300/avd.oa.16-000 Original Article Thrombosis of the Saphenous Vein Stump Varicose Vein Surgery Hiroto Rikimaru, MD, PhD We evaluated thrombus extension in the proximal

More information

Research Article Effects of Two Current Great Saphenous Vein Thermal Ablation Methods on Visual Analog Scale and Quality of Life

Research Article Effects of Two Current Great Saphenous Vein Thermal Ablation Methods on Visual Analog Scale and Quality of Life Hindawi BioMed Research International Volume 2017, Article ID 8532149, 6 pages https://doi.org/10.1155/2017/8532149 Research Article Effects of Two Current Great Saphenous Vein Thermal Ablation Methods

More information

How varicose veins occur

How varicose veins occur Varicose veins are a very common problem, generally appearing as twisting, bulging rope-like cords on the legs, anywhere from groin to ankle. Spider veins are smaller, flatter, red or purple veins closer

More information

The Management of Stasis Dermatitis and Chronic Venous Insufficiency in Patients Refractory to Conservative Therapies

The Management of Stasis Dermatitis and Chronic Venous Insufficiency in Patients Refractory to Conservative Therapies Article The Management of Stasis Dermatitis and Chronic Venous Insufficiency in Patients Refractory to Conservative Therapies Kareem Halim, 1,2, * Mark J. McElroy, 1 and John A. Lewis 3 1 Havard Medical

More information

Single-visit endovenous laser treatment and tributary procedures for symptomatic great saphenous varicose veins

Single-visit endovenous laser treatment and tributary procedures for symptomatic great saphenous varicose veins VASCULAR Ann R Coll Surg Engl 2014; 96: 279 283 doi 10.1308/003588414X13814021679474 Single-visit endovenous laser treatment and tributary procedures for symptomatic great saphenous varicose veins LS Alder,

More information

Treatment of Varicose Veins/Venous Insufficiency

Treatment of Varicose Veins/Venous Insufficiency MEDICAL POLICY 7.01.519 Treatment of Varicose Veins/Venous Insufficiency BCBSA Ref. Policy: 7.01.124 Effective Date: March 1, 2017 Last Revised: Jan. 23, 2018 Replaces: 7.01.55, 7.01.76, 7.01.515, and

More information

Laser and Radiofrequency Ablation Study (LARA study): A Randomised Study Comparing Radiofrequency Ablation and Endovenous Laser Ablation (810 nm)

Laser and Radiofrequency Ablation Study (LARA study): A Randomised Study Comparing Radiofrequency Ablation and Endovenous Laser Ablation (810 nm) Eur J Vasc Endovasc Surg (2010) 40, 246e253 Laser and Radiofrequency Ablation Study (LARA study): A Randomised Study Comparing Radiofrequency Ablation and Endovenous Laser Ablation (810 nm) S.D. Goode,

More information

Treatment of Varicose Veins

Treatment of Varicose Veins Treatment of Varicose Veins Policy Number: Original Effective Date: MM.06.016 04/15/2005 Line(s) of Business: Current Effective Date: PPO; HMO; QUEST Integration 09/28/2018 Section: Surgery Place(s) of

More information

Radiofrequency-Powered Segmental Thermal Obliteration Carried out with the ClosureFast Procedure: Results at 1 Year

Radiofrequency-Powered Segmental Thermal Obliteration Carried out with the ClosureFast Procedure: Results at 1 Year Radiofrequency-Powered Segmental Thermal Obliteration Carried out with the ClosureFast Procedure: Results at 1 Year Denis Creton, 1 Olivier Pichot, 2 Carmine Sessa, 2 and T.M. Proebstle, 3 the ClosureFast

More information

SAVE LIMBS SAVE LIVES! Endovenous Ablation for Chronic Wounds

SAVE LIMBS SAVE LIVES! Endovenous Ablation for Chronic Wounds SAVE LIMBS SAVE LIVES! Endovenous Ablation for Chronic Wounds Frank J. Tursi, DPM, FACFS Clinical Associate Professor, University of Pennsylvania/Presbyterian Foot and Ankle Consultant, Philadelphia Flyers,

More information

Endovenous Thermal vs. Endovenous Chemical Ablation What is the Best for the Patient

Endovenous Thermal vs. Endovenous Chemical Ablation What is the Best for the Patient Endovenous Thermal vs. Endovenous Chemical Ablation What is the Best for the Patient T. Noppeney, J. Noppeney Center for Vascular Diseases: Outpatient Dept. Obere Turnstrasse, Dept. for Vascular Surgery

More information

A treatment option for varicose veins. enefit" Targeted Endovenous Therapy. Formerly known as the VNUS Closure procedure E 3 COVIDIEN

A treatment option for varicose veins. enefit Targeted Endovenous Therapy. Formerly known as the VNUS Closure procedure E 3 COVIDIEN A treatment option for varicose veins. enefit" Targeted Endovenous Therapy Formerly known as the VNUS Closure procedure E 3 COVIDIEN THE VENOUS SYSTEM ANATOMY The venous system is made up of a network

More information

Current Management of C0s patient

Current Management of C0s patient Current Management of C0s patient M. Perrin Vascular Surgery, Lyon, France 1 AIM of the PRESENTATION - 1 st to estimate the prevalence of C 0s patient - 2 d to evaluate its current management - 3d to suggest

More information

[Kreussler Studies] FDA. multicenter GCP. controlled. randomized. prospective. blinded SUMMARY OF PIVOTAL STUDIES ON SCLEROTHERAPY OF VARICOSE VEINS

[Kreussler Studies] FDA. multicenter GCP. controlled. randomized. prospective. blinded SUMMARY OF PIVOTAL STUDIES ON SCLEROTHERAPY OF VARICOSE VEINS [Kreussler Studies] SUMMARY OF PIVOTAL STUDIES ON SCLEROTHERAPY OF VARICOSE VEINS FDA randomized controlled GCP blinded prospective multicenter [Sclerotherapy of Varices] Healthy legs with microfoam Chemische

More information

Endo-Thermal Heat Induced Thrombosis (E-HIT)

Endo-Thermal Heat Induced Thrombosis (E-HIT) Endo-Thermal Heat Induced Thrombosis (E-HIT) Michael Ombrellino MD FACS The Cardiovascular Care Group Clinical Associate Professor of Surgery Rutgers School of Medicine Objectives: What is E-HIT? How do

More information

Le varici recidive Recurrent varices: how to manage them?

Le varici recidive Recurrent varices: how to manage them? Le varici recidive Recurrent varices: how to manage them? Marianne De Maeseneer MD PhD, Vascular Surgeon Department of Dermatology, Rotterdam, Netherlands & Faculty of Medicine and Health Sciences University

More information

Setting The setting was an outpatient clinic. The economic study was carried out in the UK.

Setting The setting was an outpatient clinic. The economic study was carried out in the UK. Ultrasound-guided foam sclerotherapy combined with sapheno-femoral ligation compared to surgical treatment of varicose veins: early results of a randomised controlled trial Bountouroglou D G, Azzam M,

More information

Management of Side Branches and Perforating Veins

Management of Side Branches and Perforating Veins Management of Side Branches and Perforating Veins T. Noppeney Center for Vascular Diseases: Outpatient Dept. Obere Turnstrasse, Dept. for Vascular Surgery Martha-Maria Hospital (Academic Teaching Hospital

More information

Al-Metwaly Ragab Ibrahim Vascular Surgery; Al-Azhar faculty of Medicine- New Damietta, Egypt.

Al-Metwaly Ragab Ibrahim Vascular Surgery; Al-Azhar faculty of Medicine- New Damietta, Egypt. International Journal of Basic and applied Sciences. Vol. 4. No. 4. 2015. Pp. 259-264 Copyright by CRDEEP Journals. All Rights Reserved Full Length Research Paper Comparative Study between Endovenous Laser

More information

Chronic venous insufficiency (CVI) is a disorder

Chronic venous insufficiency (CVI) is a disorder Review of Chronic Venous Insufficiency From vein stripping to endovenous ablation, a look at the various techniques available for treatment. BY OLUSEGUN O. OSINBOWALE, MD, AND YUNG-WEI CHI, DO Chronic

More information

Endothermal Ablation for Venous Insufficiency. Dr. S. Kundu Medical Director The Vein Institute of Toronto

Endothermal Ablation for Venous Insufficiency. Dr. S. Kundu Medical Director The Vein Institute of Toronto Endothermal Ablation for Venous Insufficiency Dr. S. Kundu Medical Director The Vein Institute of Toronto Objective: remove the GSV from the circulation 1. Surgical - HL & stripping 2. Chemical sclerotherapy

More information

Treatment of Varicose Veins/Venous Insufficiency. Description

Treatment of Varicose Veins/Venous Insufficiency. Description Page: 1 of 24 Last Review Status/Date: March 2015 Description A variety of treatment modalities are available to treat varicose veins/venous insufficiency, including surgical approaches, thermal ablation,

More information

Influence of Warfarin on the Success of Endovenous Laser Ablation (EVLA) of the Great Saphenous Vein (GSV)

Influence of Warfarin on the Success of Endovenous Laser Ablation (EVLA) of the Great Saphenous Vein (GSV) Eur J Vasc Endovasc Surg (2009) 38, 506e510 Influence of Warfarin on the Success of Endovenous Laser Ablation (EVLA) of the Great Saphenous Vein (GSV) N.S. Theivacumar, M.J. Gough* Leeds Vascular Institute,

More information

What might bring a new wavelength for endovenous laser? Lowell S. Kabnick, MD, RPhS, FACS

What might bring a new wavelength for endovenous laser? Lowell S. Kabnick, MD, RPhS, FACS What might bring a new wavelength for endovenous laser? Lowell S. Kabnick, MD, RPhS, FACS Division of Vascular and Endovascular Surgery Faculty disclosure Lowell Kabnick, MD NOTHING TO DISCLOSE IS 1950nm

More information

ORIGINAL ARTICLES. Masatoshi Jibiki 1, Tetsuro Miyata 1,2, Sachiko Futatsugi 3, Mitsumasa Iso 3 and Yasutaka Sakanushi 3.

ORIGINAL ARTICLES. Masatoshi Jibiki 1, Tetsuro Miyata 1,2, Sachiko Futatsugi 3, Mitsumasa Iso 3 and Yasutaka Sakanushi 3. Effect of the wide-spread use of endovenous laser ablation on the treatment of varicose veins in Japan: a large-scale, single institute study Masatoshi Jibiki 1, Tetsuro Miyata 1,2, Sachiko Futatsugi 3,

More information

Management of Superficial Reflux: Which option, when? Kathleen Gibson, MD Lake Washington Vascular Surgeons Bellevue, WA

Management of Superficial Reflux: Which option, when? Kathleen Gibson, MD Lake Washington Vascular Surgeons Bellevue, WA Management of Superficial Reflux: Which option, when? Kathleen Gibson, MD Lake Washington Vascular Surgeons Bellevue, WA DISCLOSURES Kathleen Gibson, MD Consultant/Advisory Board: BTG, Medtronic Speakers

More information

Original Policy Date

Original Policy Date MP 7.01.104 Treatment of Varicose Veins Medical Policy Section Surgery Issue 12/2013 Original Policy Date 12/2013 Last Review Status/Date Local policy/12/2013 Return to Medical Policy Index Disclaimer

More information

BlueCross BlueShield of Tennessee Medical Policy Manual

BlueCross BlueShield of Tennessee Medical Policy Manual Varicose Vein Treatments for the Lower Extremities DESCRIPTION BlueCross BlueShield of Tennessee Medical Policy Manual Varicose veins, enlarged, dilated, and tortuous vessels are a common clinical manifestation

More information

Clinical Policy Title: Varicose vein treatments

Clinical Policy Title: Varicose vein treatments Clinical Policy Title: Varicose vein treatments Clinical Policy Number: CCP.1131 Effective Date: January 1, 2014 Initial Review Date: August 20, 2014 Most Recent Review Date: August 30, 2018 Next Review

More information

Date: A. Venous Health History Form. Patient please complete questions Primary Care Physician:

Date: A. Venous Health History Form. Patient please complete questions Primary Care Physician: E S Insurance: 2 nd Insurance: Wait time: Date: A. Venous Health History Form Patient please complete questions 1-12 Patient Name: SSN#: Date of Birth: Primary Care Physician: What is the reason for your

More information

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY Original Issue Date (Created): July 12, 2003 Most Recent Review Date (Revised): May 20, 2014 Effective Date: October 1, 2014 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT

More information

Treatment of Venous ulcers utilizing n-butyl Cyanoacrylate (Super Glue)

Treatment of Venous ulcers utilizing n-butyl Cyanoacrylate (Super Glue) Treatment of Venous ulcers utilizing n-butyl Cyanoacrylate (Super Glue) Awais Siddique MD Endovascular Radiologist AZH WAVE CENTERS Milwaukee WI Venous disease Etiology Are the result of Venous valvular

More information

The occlusion rate and patterns of saphenous vein after radiofrequency ablation

The occlusion rate and patterns of saphenous vein after radiofrequency ablation J Korean Surg Soc 2013;84:107-113 http://dx.doi.org/10.4174/jkss.2013.84.2.107 ORIGINAL ARTICLE JKSS Journal of the Korean Surgical Society pissn 2233-7903 ㆍ eissn 2093-0488 The occlusion rate and patterns

More information

LINC, Christine Teichert, MD University Medicine of Rostock, Dept. of diagnostic and interventional radiology, Germany

LINC, Christine Teichert, MD University Medicine of Rostock, Dept. of diagnostic and interventional radiology, Germany Comparison of the efficacy, safety, the primary and secondary technical success of the endovenous nonthermal, tumescensless mechanochemical ablation of varicose veins with the subjective outcome using

More information

S Shivakumar, Gopi Tupkar, N Ravishankar and Divakar. The Pharma Innovation Journal 2017; 6(7):

S Shivakumar, Gopi Tupkar, N Ravishankar and Divakar. The Pharma Innovation Journal 2017; 6(7): 2017; 6(7): 120-128 ISSN (E): 2277-7695 ISSN (P): 2349-8242 NAAS Rating 2017: 5.03 TPI 2017; 6(7): 120-128 2017 TPI www.thepharmajournal.com Received: 20-05-2017 Accepted: 21-06-2017 S Shivakumar Gopi

More information

Recurrent Varicose Veins We All See Them

Recurrent Varicose Veins We All See Them We All See Them November 4, 2017 Austin, TX Arlington Heights, IL No conflicts Terminology REVAS REcurrent Varices After Surgery PREVAIT PREsence of Varices After Interventional Treatment Recurrent varices

More information

Outcome of different endovenous laser wavelengths for great saphenous vein ablation

Outcome of different endovenous laser wavelengths for great saphenous vein ablation From the American Venous Forum Outcome of different endovenous laser wavelengths for great saphenous vein ablation Lowell S. Kabnick, MD, FACS, Morristown and Newark, NJ Objective: The objective of this

More information

Treatment of Varicose Veins/Venous Insufficiency

Treatment of Varicose Veins/Venous Insufficiency Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided

More information

RADIOFREQUENCY ABLATION. Drs PIRET V, BERGERON P MEET CANNES 2009

RADIOFREQUENCY ABLATION. Drs PIRET V, BERGERON P MEET CANNES 2009 RADIOFREQUENCY ABLATION Drs PIRET V, BERGERON P MEET CANNES 2009 Superficial Venous Disease: EPIDEMIOLOGY Touch 75% of french population at different degrees (45.10 6 ) 25% needs medical care (11.10 6

More information

Varicose veins. Natural history, assessment and management. Arteries and veins. Why do people get varicose veins? Classification of venous disease

Varicose veins. Natural history, assessment and management. Arteries and veins. Why do people get varicose veins? Classification of venous disease Arteries and veins Neil Wright Rob Fitridge Varicose veins Natural history, assessment and management Background Varicose veins are a common condition. Presentations can range from those that are noticed

More information

Venous Disease and Leg Ulcers. Edward G Mackay MD St. Petersburg, FL NCVH 2015 Orlando, FL

Venous Disease and Leg Ulcers. Edward G Mackay MD St. Petersburg, FL NCVH 2015 Orlando, FL Venous Disease and Leg Ulcers Edward G Mackay MD St. Petersburg, FL NCVH 2015 Orlando, FL Disclosures Stocks Endoshape Sapheon Medical Advisory Board BTG, Boston Scientific Venous Leg Ulcer Most common

More information

JOURNAL OF VASCULAR SURGERY Volume 51, Number 6 Schwarz et al 1475 (linear array 8-3 MHz [ZONARE, Mountain View, Calif]) using a standardized examinat

JOURNAL OF VASCULAR SURGERY Volume 51, Number 6 Schwarz et al 1475 (linear array 8-3 MHz [ZONARE, Mountain View, Calif]) using a standardized examinat Endovenous laser ablation of varicose veins with the 1470-nm diode laser Thomas Schwarz, MD, Eva von Hodenberg, MD, Christian Furtwängler, BS, Aljoscha Rastan, MD, Thomas Zeller, MD, and Franz-Josef Neumann,

More information

Jan T. Christenson, MD, a Salah Gueddi, MD, b Gino Gemayel, MD, a and Henri Bounameaux, MD, b Geneva, Switzerland

Jan T. Christenson, MD, a Salah Gueddi, MD, b Gino Gemayel, MD, a and Henri Bounameaux, MD, b Geneva, Switzerland Prospective randomized trial comparing endovenous laser ablation and surgery for treatment of primary great saphenous varicose veins with a 2-year follow-up Jan T. Christenson, MD, a Salah Gueddi, MD,

More information

Mechanochemical endovenous ablation in the treatment of varicose veins van Eekeren, Ramon

Mechanochemical endovenous ablation in the treatment of varicose veins van Eekeren, Ramon University of Groningen Mechanochemical endovenous ablation in the treatment of varicose veins van Eekeren, Ramon DOI: 10.1053/j.semvascsurg.2015.02.002 10.1016/j.ejvs.2012.12.004 10.1016/j.jvsv.2014.01.001

More information

N.S. Theivacumar, R. Darwood, M.J. Gough* KEYWORDS Neovascularisation; Recurrence; Varicose vein; EVLA; Sapheno-femoral junction; GSV

N.S. Theivacumar, R. Darwood, M.J. Gough* KEYWORDS Neovascularisation; Recurrence; Varicose vein; EVLA; Sapheno-femoral junction; GSV Eur J Vasc Endovasc Surg (2009) 38, 203e207 Neovascularisation and Recurrence 2 Years After Varicose Vein Treatment for Sapheno-Femoral and Great Saphenous Vein Reflux: A Comparison of Surgery and Endovenous

More information

Endovenous Laser Ablation (EVLA) to Treat Recurrent Varicose Veins

Endovenous Laser Ablation (EVLA) to Treat Recurrent Varicose Veins Eur J Vasc Endovasc Surg (2011) 41, 691e696 Endovenous Laser Ablation (EVLA) to Treat Recurrent Varicose Veins N.S. Theivacumar, M.J. Gough* Leeds Vascular Institute, The General Infirmary at Leeds, Great

More information

Acta Medica Marisiensis 2015;61(2):94-99

Acta Medica Marisiensis 2015;61(2):94-99 Acta Medica Marisiensis 2015;61(2):94-99 DOI: 10.1515/amma-2015-0030 RESEARCH ARTICLE Socio-demographic Characteristics of Patients Diagnosed with Advanced Chronic Venous Insufficiency (C4-C6) Correlated

More information

Epidemiology: Prevalence

Epidemiology: Prevalence Epidemiology: Prevalence More than 30 million Americans suffer from varicose veins or a more serious form of venous disease called Chronic Venous Insufficiency (CVI). 1 Of the over 30 million Americans

More information

Validation of the new venous severity scoring system in varicose vein surgery

Validation of the new venous severity scoring system in varicose vein surgery Validation of the new venous severity scoring system in varicose vein surgery Stavros K. Kakkos, MD, MSc, a,b Marco A. Rivera, MD, MSc, a Miltiadis I. Matsagas, MD, a Miltos K. Lazarides, MD, c Peter Robless,

More information

How to choose which treatment method(s) to use for a particular varicose veins patient ESTABLISHING A TREATMENT PLAN.

How to choose which treatment method(s) to use for a particular varicose veins patient ESTABLISHING A TREATMENT PLAN. How to choose which treatment method(s) to use for a particular varicose veins patient ESTABLISHING A TREATMENT PLAN Surgeon Dr G Mark Malouf Sydney Australia Following History and Physical examination

More information

Treatment of Varicose Veins/Venous Insufficiency Corporate Medical Policy

Treatment of Varicose Veins/Venous Insufficiency Corporate Medical Policy Treatment of Varicose Veins/Venous Insufficiency Corporate Medical Policy File name: Treatment of Varicose Veins/Venous Insufficiency File code: UM.SURG.03 Origination: 9/01/2010 Last Review: 03/2015 Next

More information

Current Management of Varicose Veins

Current Management of Varicose Veins Current Management of Varicose Veins Michael J. Heidenreich, MD St. Joseph Mercy Hospital Ann Arbor, MI March 23, 2013 Nothing to disclose History Prevalence Anatomy Risk factors Clinical manifestations

More information

Approve Date: 10/20/2014 Revise Dates: 04/21/2016 Next Review: 10/20/2016 Review Dates: 10/20/2015

Approve Date: 10/20/2014 Revise Dates: 04/21/2016 Next Review: 10/20/2016 Review Dates: 10/20/2015 Policy Number: 1025 Policy History Approve Date: 10/20/2014 Revise Dates: 04/21/2016 Next Review: 10/20/2016 Review Dates: 10/20/2015 Preauthorization All Plans Benefit plans vary in coverage and some

More information

Combined Endovenous Laser Therapy and Ambulatory Phlebectomy: Refinement of a New Technique

Combined Endovenous Laser Therapy and Ambulatory Phlebectomy: Refinement of a New Technique Eur J Vasc Endovasc Surg 32, 725e729 (2006) doi:10.1016/j.ejvs.2006.06.002, available online at http://www.sciencedirect.com on Combined Endovenous Laser Therapy and Ambulatory Phlebectomy: Refinement

More information

EVLT with foam sclerotherapy for varicose veins: a single unit study

EVLT with foam sclerotherapy for varicose veins: a single unit study International Surgery Journal Wasim MD et al. Int Surg J. 2018 Jul;5(7):2437-2443 http://www.ijsurgery.com pissn 2349-3305 eissn 2349-2902 Original Research Article DOI: http://dx.doi.org/10.18203/2349-2902.isj20182461

More information

Date: A. Venous Health History Form. Patient please complete questions Primary Care Physician:

Date: A. Venous Health History Form. Patient please complete questions Primary Care Physician: E S Insurance: 2 nd Insurance: Wait time: Date: A. Venous Health History Form Patient please complete questions 1-12 Patient Name: SSN#: Date of Birth: Primary Care Physician: What is the reason for your

More information

Abstracts Vaeshartelt 14 mei 2011 Résumés Vaeshartelt mai 2011

Abstracts Vaeshartelt 14 mei 2011 Résumés Vaeshartelt mai 2011 Abstracts Vaeshartelt 14 mei 2011 Résumés Vaeshartelt mai 2011 1. Treatment of ileofemoral venous occlusive disease: clinical experience M. de Wolf, MD 1 ; J. Grommes, MD 2 ; C. Arnoldussen, MD 3 ; R.

More information

The role of new reflux of accessory veins in clinical recurrence of varicose veins after endovascular laser ablation (EVLA)

The role of new reflux of accessory veins in clinical recurrence of varicose veins after endovascular laser ablation (EVLA) Cyprus Society of Vascular and Endovascular Surgery The role of new reflux of accessory veins in clinical recurrence of varicose veins after endovascular laser ablation (EVLA) Toursidis Achilleas, MD,

More information

The role of ultrasound duplex in endovenous procedures

The role of ultrasound duplex in endovenous procedures The role of ultrasound duplex in endovenous procedures Neophytos A. Zambas MD, PhD Vascular Surgeon Polyclinic Ygia, Limassol, Cyprus ΚΕΑΕΧ ΚΥΠΡΙΑΚΗ ΕΤΑΙΡΕΙΑ ΑΓΓΕΙΑΚΗΣ ΚΑΙ ΕΝΔΑΓΓΕΙΑΚΗΣ ΧΕΙΡΟΥΡΓΙΚΗΣ Pre

More information

COMMISSIONING POLICY

COMMISSIONING POLICY Ref No. 1a7.5 COMMISSIONING POLICY Surgery for venous disease of the leg (Varicosities of the Long Saphenous Vein) April 2011 CONTENTS Section Page Summary 2 1. Background 2 2. Criteria for eligibility

More information

The Use of Adjunctive Venography and Endovascular Manoeuvres In The Treatment of Saphenous Vein Insufficiency. A Prospective, Multi-centre Study

The Use of Adjunctive Venography and Endovascular Manoeuvres In The Treatment of Saphenous Vein Insufficiency. A Prospective, Multi-centre Study The Use of Adjunctive Venography and Endovascular Manoeuvres In The Treatment of Saphenous Vein Insufficiency A Prospective, Multi-centre Study Ramon L. Varcoe, MBBS, MS, FRACS, PhD Associate Professor

More information

UNDERSTANDING VEIN DISEASE. UC EN - For use in the U.S. only

UNDERSTANDING VEIN DISEASE. UC EN - For use in the U.S. only UNDERSTANDING VEIN DISEASE UC201706537 EN - For use in the U.S. only Do you need to sit down during your work day because your legs ache and/or swell? Do you miss out on doing the activities you love because

More information